関連する実験動画
Updated: Sep 10, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
リウマチ性関節炎に関連したインタースティシャル肺疾患患者の総合分析
Ji-Won Kim1, Ju-Yang Jung1, Chang-Hee Suh1
1Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea.
The Korean journal of internal medicine
|August 27, 2025
まとめ
リウマチ性関節炎に関連した関節間肺疾患 (RA- ILD) の患者は,特に通常の関節間肺炎 (UIP) の患者では,疾患の進行と死亡率をしばしば経験する. 早期発見とパーソナライズされた管理は,RA-ILDの成果を改善するための鍵です.
科学分野:
- リウマトロジ
- 肺科
- 放射線科
背景:
- リウマチ性関節炎に関連したインタースティシャル肺疾患 (RA- ILD) は,重大な臨床的課題です.
- RA-ILDの人口統計,疾患の特徴,および予後要因を理解することは,患者の管理に不可欠です.
研究 の 目的:
- RA-ILD患者の人口統計,疾患の特徴,および治療を調査する.
- RA患者におけるインタースティシャル肺疾患 (ILD) の進行および死亡率に関連する要因を特定する.
主な方法:
- 1999年1月から2022年3月までの間に診断されたRA- ILD患者 (18歳以上) の遡及研究.
- 診断は胸部CTスキャンで確認され,肺機能検査 (PFT) とフォローアップCTを用いて進行をモニターした.
- ILDの進行と死亡率の予測要因を決定するために,ロジスティック回帰分析を使用した.
主要な成果:
- 研究対象は64. 3歳の患者で,男性の割合は48. 3%でした. 通常のインタースティシャル肺炎 (UIP) のパターンは,症例の60. 3%で観察されました.
- ILDは平均4年間の追跡期間中に58. 3%の患者で進行し,死亡率は21. 2%でした.
- ILDの進行とUIPパターンは死亡率の有意な予測指標であり,メトトレキサートの使用は影響を示さなかった.
結論:
- RA- ILD患者は様々な臨床プロファイルを示し,ILDの持続時間とUIPパターンが予後に影響します.
- パーソナライズされた管理戦略と密接なモニタリングは,RA-ILD患者の治療結果を改善するために不可欠です.
さらに関連する動画
関連する概念動画
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Rheumatic Heart Disease I: Introduction
39
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
39
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K

